Epidemiology and Genetics, Morbidity and Mortality of Lipid-Associated Cardiovascular Disorders

Publisher： Karger

E-ISSN： 1424-0556|5|1|29-33

ISSN： 1422-9528

Source： Heart Drug, Vol.5, Iss.1, 2005-02, pp. : 29-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metformin therapy is associated with reduced cardiovascular morbidity and mortality

By  

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Cardiovascular Morbidity and Mortality in Obstructive Sleep Apnea

By  

Current Pharmaceutical Design, Vol. 14, Iss. 32, 2008-11 ,pp. : 3466-3473

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet Agents in the Prevention of Cardiovascular Morbidity and Mortality in Older Patients With Vascular Disease

By Aronow W.S.  

Drugs & Aging, Vol. 15, Iss. 2, 1999-08 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Morbidity and Mortality Associated with Pharmacotherapy. Evolution and Current Concept of Drug-Related Problems

By  

Current Pharmaceutical Design, Vol. 10, Iss. 31, 2004-12 ,pp. : 3947-3967

Bentham Science Publishers

Access to resources Recommend Favorite

Acute Beta Blocker Overdose: Factors Associated with the Development of Cardiovascular Morbidity

By Love Jeffrey  

Journal of Toxicology. Clinical Toxicology, Vol. 38, Iss. 3, 2000-01 ,pp. : 275-281

Informa Healthcare

Access to resources Recommend Favorite